|
Volumn 2, Issue 2, 2007, Pages
|
Inadequate evidence to support phase III studies of albumin in severe malaria
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
GELATIN SUCCINATE;
PHENYTOIN;
BRAIN MALARIA;
BRAIN PROTECTION;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COMATOSE PATIENT;
DISEASE SEVERITY;
FACTORIAL DESIGN;
FLUID RESUSCITATION;
HUMAN;
LETTER;
LUNG EDEMA;
MORTALITY;
NEUROPROTECTION;
OUTCOMES RESEARCH;
PATIENT SAFETY;
RISK REDUCTION;
STATISTICAL SIGNIFICANCE;
|
EID: 34249848611
PISSN: None
EISSN: 15555887
Source Type: Journal
DOI: 10.1371/journal.pctr.0020004 Document Type: Letter |
Times cited : (3)
|
References (7)
|